⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Yttrium Y 90 Resin Microspheres Data Collection in Unresectable Liver Cancer: the RESIN Study

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Yttrium Y 90 Resin Microspheres Data Collection in Unresectable Liver Cancer: the RESIN Study

Official Title: Radiation-Emitting SIR-Spheres in Non-resectable (RESIN) Liver Tumor Patient Study

Study ID: NCT02685631

Study Description

Brief Summary: This research registry studies Yttrium Y 90 resin microspheres in collecting data from patients with liver cancer not capable of being removed by surgery (unresectable) for the radiation-emitting Selective Internal Radiation-Spheres (SIR-spheres) in non-resectable (RESIN) liver tumor registry. The information generated will help doctors better understand treatment patterns involving Y90 therapy, gain additional insights in the long-term outcomes for patients, as well as guide future research for using Y90 therapy, especially for those conditions where data is currently very limited or lacking.

Detailed Description: PRIMARY OBJECTIVES: I. The principal objective of the RESIN registry is to evaluate response to therapy using objective response criteria such as modified Response Evaluation Criteria in Solid Tumors (mRECIST) or European Association for Study of the Liver (EASL). The response criteria used will depend on tumor type treated and local policies as this is a registry and not a formal research study. Secondary criteria include overall survival, time to progression (TTP) and toxicity. OUTLINE: Patients receiving Yttrium Y90 resin microspheres treatment as part of their overall oncologic management are added in the RESIN registry database to collect and document information including: patient demographics (gender/age), previous oncologic treatments, details of Yttrium Y90 resin microspheres treatment, and to track outcomes and complications.

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

University of Alabama, Birmingham, Alabama, United States

University of Arizona Health Sciences, Tucson, Arizona, United States

University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States

Cedars-Sinai Medical Center, Los Angeles, California, United States

California Pacific Medical Center, San Francisco, California, United States

University of California, San Francisco, San Francisco, California, United States

Stanford University, Stanford, California, United States

University of Colorado, Denver, Denver, Colorado, United States

Sky Ridge Medical Center, Englewood, Colorado, United States

Christiana Care Health System, Wilmington, Delaware, United States

Georgetown University, Washington, District of Columbia, United States

Baptist Hospital of Miami, Miami, Florida, United States

University of Miami, Miami, Florida, United States

Sarasota Memorial Hospital, Sarasota, Florida, United States

Tampa General Hospital, Tampa, Florida, United States

Cancer Treatment Centers of America, Atlanta, Georgia, United States

Emory University, Atlanta, Georgia, United States

Piedmont Hospital, Atlanta, Georgia, United States

Advocate Christ Medical Center, Oak Lawn, Illinois, United States

University of Kansas Medical Center, Kansas City, Kansas, United States

Ochsner Clinic Foundation, New Orleans, Louisiana, United States

University of Maryland School of Medicine, Baltimore, Maryland, United States

Massachusetts General Hospital, Boston, Massachusetts, United States

University of Minnesota, Minneapolis, Minnesota, United States

Saint Louis University, Saint Louis, Missouri, United States

Albany Medical Center, Albany, New York, United States

Roswell Park Cancer Institute, Buffalo, New York, United States

Northwell Health- Lenox Hill Hospital, New York, New York, United States

Carolinas Medical Center, Charlotte, North Carolina, United States

Wake Forest Medical Center, Winston-Salem, North Carolina, United States

Cleveland Clinic, Cleveland, Ohio, United States

University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States

Oregon Health & Science University, Portland, Oregon, United States

University of Pennsylvania Cancer Center, Philadelphia, Pennsylvania, United States

Penn State Health Saint Joseph Medical Center, Reading, Pennsylvania, United States

Spartanburg Regional Healthcare System, Spartanburg, South Carolina, United States

Sanford USD Medical Center, Sioux Falls, South Dakota, United States

Vanderbilt University/Ingram Cancer Center, Nashville, Tennessee, United States

Methodist Health System, Dallas, Texas, United States

Houston Methodist Hospital, Houston, Texas, United States

The University of Utah, Salt Lake City, Utah, United States

Providence Sacred Heart Medical Center and Children's Hospital, Spokane, Washington, United States

Contact Details

Name: Daniel Brown

Affiliation: Vanderbilt University/Ingram Cancer Center

Role: PRINCIPAL_INVESTIGATOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: